Second Euro Health Forum "EXPERTISE SCIENTIFIQUE ET DECISION PUBLIQUE EN EUROPE"
November 25th, 2005, Hotel Lutetia, Paris
Search:
17th International Congress on Anti-Cancer Treatment
2nd Franco-British Meeting in Health Economics
Assessment of the incremental cost of drotrecogin alpha with respect to standard care in the treatment of severe sepsis in real practice.
Rapport d’activité au parlement et au gouvernement
Home
Latest News...
17th International Congress on Anti-Cancer Treatment
January 30th - February 2th 2006, Palais des Congrès, Paris, France. Abstracts deadline : October 28, 2005.
2nd Franco-British Meeting in Health Economics
January 4-6, 2006 - London, UK.
3 presentations >>
Assessment of the incremental cost of drotrecogin alpha with respect to standard care in the treatment of severe sepsis in real practice.
Payet S., Riou-Franca L., Le Lay K., Launois R. 2nd Franco-British Meeting in Health Economics - London, January 4-6, 2006
A cost-utility analysis of first line chemotherapy regimens in the treatment of metastatic breast cancer after anthracyclines failure.
Le Lay K., Payet S., Riou-Franca L., Chemali N., Launois R. 2nd Franco-British Meeting in Health Economics - London, January 4-6, 2006
Impact of the Propensity Score estimation method when matching patients to reduce recruitment bias in observational studies.
Riou-Franca L., Payet S., Le Lay K., Launois R. 2nd Franco-British Meeting in Health Economics - London, January 4-6, 2006
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis with multiple organ failure
Riou-Franca L., Launois R., Le Lay K., Aegerter P., Bouhassira M., Meshaka P., Guidet B. Intl. J. Techn. Ass. Health Care, January 2006, Volume 22:1.
Estimation of the cost-effectiveness of stroke units in France compared with conventional care
Launois R., Giroud M., Megnigbeto AC., Le Lay K., Presente G., Durand I., Gaudin A.F. Stroke 2004 ; 35 : 770-775.
Rapport d’activité au parlement et au gouvernement
1er semestre 2005 - Haute Autorité de Santé (HAS)
17th International Congress on Anti-Cancer Treatment
